关注
Natalia Satchiko Hojo-Souza
Natalia Satchiko Hojo-Souza
Centro de Tecnologia de Vacinas
在 minas.fiocruz.br 的电子邮件经过验证
标题
引用次数
引用次数
年份
On the analysis of mortality risk factors for hospitalized COVID-19 patients: A data-driven study using the major Brazilian database
FSH de Souza, NS Hojo-Souza, BDO Batista, CM da Silva, DL Guidoni
PloS one 16 (3), e0248580, 2021
1212021
Daily rhythms of TNFα expression and food intake regulate synchrony of plasmodium stages with the host circadian cycle
IC Hirako, PA Assis, NS Hojo-Souza, G Reed, H Nakaya, DT Golenbock, ...
Cell host & microbe 23 (6), 796-808. e6, 2018
792018
Predicting the disease outcome in COVID-19 positive patients through Machine Learning: a retrospective cohort study with Brazilian data
FSH De Souza, NS Hojo-Souza, EB Dos Santos, CM Da Silva, ...
Frontiers in Artificial Intelligence 4, 579931, 2021
752021
Second wave of COVID-19 in Brazil: younger at higher risk
FSH de Souza, NS Hojo-Souza, CM da Silva, DL Guidoni
European journal of epidemiology 36, 441-443, 2021
662021
On the cytokine/chemokine network during Plasmodium vivax malaria: new insights to understand the disease
NS Hojo-Souza, DB Pereira, FSH de Souza, TA de Oliveira Mendes, ...
Malaria journal 16, 1-10, 2017
402017
Pteridium aquilinum: o que sabemos eo que ainda falta saber
NS Hojo-Souza, CM Carneiro, RC Santos
Bioscience Journal 26 (5), 798-808, 2010
232010
Profile of Brazilian inpatients with COVID-19 vaccine breakthrough infection and risk factors for unfavorable outcome
MAS de Jesus, NS Hojo-Souza, TR de Moraes, DL Guidoni, ...
Revista panamericana de salud publica 46, e106, 2023
202023
Contributions of IFN-γ and granulysin to the clearance of Plasmodium yoelii blood stage
NS Hojo-Souza, PO de Azevedo, JT de Castro, A Teixeira-Carvalho, ...
PLoS Pathogens 16 (9), e1008840, 2020
202020
CD4+ T cells apoptosis in Plasmodium vivax infection is mediated by activation of both intrinsic and extrinsic pathways
NS Hojo-Souza, DB Pereira, TAO Mendes, LSA Passos, ...
Malaria journal 14, 1-7, 2015
202015
Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein
JT Castro, P Azevedo, MJ Fumagalli, NS Hojo-Souza, N Salazar, ...
Nature communications 13 (1), 4831, 2022
172022
Phenotypic profiling of CD8+ T cells during Plasmodium vivax blood-stage infection
NS Hojo-Souza, DB Pereira, LSA Passos, PH Gazzinelli-Guimarães, ...
BMC Infectious Diseases 15, 1-9, 2015
142015
Differential requirement of neutralizing antibodies and T cells on protective immunity to SARS-CoV-2 variants of concern
PO Azevedo, NS Hojo-Souza, LP Faustino, MJ Fumagalli, IC Hirako, ...
npj Vaccines 8 (1), 15, 2023
92023
An overview of Brazilian working age adults vulnerability to COVID-19
FSH de Souza, NS Hojo-Souza, DCR de Oliveira, CM Silva, DL Guidoni
Scientific Reports 12 (1), 2798, 2022
92022
Uptake of Plasmodium chabaudi hemozoin drives Kupffer cell death and fuels superinfections
IC Hirako, MM Antunes, RM Rezende, NS Hojo-Souza, MM Figueiredo, ...
Scientific Reports 12 (1), 19805, 2022
82022
A temporal study of Brazilian pregnant and postpartum women vulnerability for COVID-19: Characteristics, risk factors and outcomes
NS Hojo-Souza, DL Guidoni, CM Da Silva, FSH De Souza
The Lancet Regional Health–Americas 9, 2022
82022
Pteridium aquilinum: what we know and what is yet to be learnt.
NS Hojo-Souza, CM Carneiro, RC Santos
82010
Protective Immunity against Gamma and Zeta Variants after Inactivated SARS-CoV-2 Virus Immunization
MJ Fumagalli, LA Castro-Jorge, TFC Fraga-Silva, PO de Azevedo, ...
Viruses 13 (12), 2440, 2021
72021
ASP-2/Trans-sialidase chimeric protein induces robust protective immunity in experimental models of Chagas’ disease
JT Castro, R Brito, NS Hojo-Souza, B Azevedo, N Salazar, CP Ferreira, ...
npj Vaccines 8 (1), 81, 2023
62023
Clinical symptom profile of hospitalized COVID-19 Brazilian patients according to SARS-CoV-2 variants
NS Hojo-Souza, DL Guidoni, FSH de Souza
Epidemiology and Health 45, 2023
52023
The immune response in Chagas disease and its role in the variability of clinical expression
D Walderez, NS Hojo-Souza, KJ Gollob
Revista Española de Salud Pública, 25-32, 2013
32013
系统目前无法执行此操作,请稍后再试。
文章 1–20